Congenital melanocytic nevi management: answer
Vol. 5 No. 1 (2016), Articles
Vol. 5 No. 1 (2016)

Congenital melanocytic nevi management: answer

Articles
https://doi.org/10.7363/050128
Published 2016-03-30
Stefania Guida
Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
Giacomo Giovanni Urtis
Istituto DermoEstetico (IDE), Milan, Italy
Giuseppe Rubino
Istituto DermoEstetico (IDE), Milan, Italy
Giovanni Pellacani
Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
Francesca Farnetani
Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
JPNIM Vol. 5 N. 1 - Cover
PDF

Keywords

melanocytic nevi
congenital nevi
melanoma
management

How to Cite

Guida, S., Urtis, G. G., Rubino, G., Pellacani, G., & Farnetani, F. (2016). Congenital melanocytic nevi management: answer. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM), 5(1), e050128. https://doi.org/10.7363/050128
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Congenital melanocytic nevi (CMN) are melanocytic lesions presenting at birth or appearing during the first weeks of life. CMN are usually grouped, according to size, in three categories: 1) small congenital nevi (SCN), measuring less than 1.5 cm in greatest diameter; 2) intermediate congenital nevi (ICN) that are 1.5-19.9 cm in greatest diameter; 3) large or giant nevi, larger than 20 cm in greatest diameter. Although the risk of a nevus evolving into a melanoma is low, all congenital nevi, particularly giant nevi, can be considered potential melanoma precursors. Furthermore, other criteria should be considered for an appropriate management of these lesions.

https://doi.org/10.7363/050128
PDF